AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 263: R1030-R1034, 1992;
0363-6119/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stone, J. D.
Right arrow Articles by Share, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, J. D.
Right arrow Articles by Share, L.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 263, Issue 5 1030-R1034, Copyright © 1992 by American Physiological Society

ARTICLES

Sex differences in central cholinergic and angiotensinergic control of vasopressin release

J. D. Stone, J. T. Crofton and L. Share
Department of Physiology and Biophysics, University of Tennessee, Memphis 38163.

In conscious, unrestrained rats, the intracerebroventricular injection of the cholinergic agonist, carbachol, or angiotensin II resulted in the transient stimulation of vasopressin secretion, elevation of mean arterial blood pressure, and reduction of heart rate. After the injection of carbachol (25 ng) into a lateral cerebral ventricle, the plasma vasopressin concentration in male rats was increased to twice that of female rats in each phase of the estrous cycle; mean arterial blood pressure was elevated more in males than females, whereas heart rate fell to the same extent in both sexes. In contrast, the increase in the plasma vasopressin concentration of males after the injection of angiotensin II (20 ng) was one-half that of females, and the hypertensive and bradycardic responses were similar in both sexes. Phase of the female estrous cycle had no effect on the responses to either agent. These findings indicate that central cholinergic and angiotensinergic mechanisms controlling vasopressin release are influenced differently by gender. The role of the gonadal steroid hormones in these mechanisms remains to be determined.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. L. Calzone, C. Silva, D. L. Keefe, and N. S. Stachenfeld
Progesterone does not alter osmotic regulation of AVP
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R2011 - R2020.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
N. S. Stachenfeld, A. E. Splenser, W. L. Calzone, M. P. Taylor, and D. L. Keefe
Genome and Hormones: Gender Differences in Physiology: Selected Contribution: Sex differences in osmotic regulation of AVP and renal sodium handling
J Appl Physiol, October 1, 2001; 91(4): 1893 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. S. Stachenfeld, L. Dipietro, S. F. Palter, and E. R. Nadel
Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R187 - R195.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online